 |
| Global Brachytherapy Market Size |
Brachytherapy involves radiation therapy using radioactive sources placed
inside or next to the area requiring treatment. Brachytherapy is widely used in
the treatment of cervical, prostate, breast, and skin cancer. It delivers
higher radiation doses directly to the tumor while limiting exposure to nearby
healthy tissue. This results in better survival and cure rates with minimal
side effects compared to other radiation therapies.
The global
brachytherapy market is estimated to be valued at US$ 972.21 Mn in 2023 and is expected to exhibit a CAGR of 19% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
There has been an increased use of brachytherapy in the treatment of cancers in
recent years. Advancements in brachytherapy technologies allow for more
targeted radiation and precise dose delivery to tumors. Image-guided
brachytherapy systems enable real-time tracking and visualization of
radioactive sources inside the body during treatment. This ensures radiation is
delivered exactly as planned and improves treatment outcomes. Manufacturers are
also developing new radiation delivery methods such as high and low dose rate
brachytherapy that can be used depending on the cancer type and stage. This has
expanded the applications of brachytherapy and contributed to the accelerated
growth of the overall brachytherapy market.
Segment Analysis
Breast cancer brachytherapy helps in delivering higher and more focused
radiation dose to the site of tumor while minimizing radiation exposure to
nearby healthy tissues. This makes it an effective treatment option for early
stage breast cancer.
Key Takeaways
Global
Brachytherapy Market Size is expected to witness high growth over the
forecast period of 2023 to 2030. The global brachytherapy market is estimated
to be valued at US$ 972.21 Mn in 2023
and is expected to exhibit a CAGR of 19%
over the forecast period 2023 to 2030.
Regional analysis
North America currently dominates the global brachytherapy market. However,
Asia Pacific is expected to witness the fastest growth over the forecast period
supported by growing healthcare expenditure, increasing patient awareness and
improving access to advanced cancer care across developing nations.
Key players
Key players operating in the brachytherapy market are Varian Medical Systems,
Elekta AB, Becton, Dickinson and Company, IsoRay, Inc., Eckert & Ziegler
BEBIG, and iCAD. Varian Medical Systems and Elekta AB currently hold the
leading market position with their diverse product portfolios for brachytherapy
procedures.
Get More Insights On This Topic: https://www.ukwebwire.com/brachytherapy-market-scope/